Xing Feng
- Cancer Research top 5%
- MicroRNA in disease regulation 2
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 6
- Ubiquitin and proteasome pathways 4
- Histone Deacetylase Inhibitors Research 3
- Cancer-related gene regulation 3
- RNA modifications and cancer 3
- Biochemical and Molecular Research 2
- Physiology top 10%
-
- Autophagy in Disease and Therapy 3
- Journals
- Nucleic Acids Research (1 paper)The Journal of Experimental Medicine (1 paper)The EMBO Journal (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Xing Feng
28 papers receiving 996 citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Cancer Research 337
- Molecular Biology 823
- Physiology 30
- Epidemiology 192
- Oncology 129
Countries citing papers authored by Xing Feng
This map shows the geographic impact of Xing Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing Feng more than expected).
Fields of papers citing papers by Xing Feng
This network shows the impact of papers produced by Xing Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing Feng. The network helps show where Xing Feng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xing Feng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 6 | |
| 4 | 2023 | 10 | |
| 5 | 2022 | 11 | |
| 6 | 2021 | 14 | |
| 7 | 2021 | 4 | |
| 8 | 2020 | 9 | |
| 9 | 2020 | 33 | |
| 10 | 2020 | 47 | |
| 11 | 2020 | 6 | |
| 12 | 2020 | 120 | |
| 13 | 2020 | 1 | |
| 14 | 2019 | 13 | |
| 15 | 2019 | 5 | |
| 16 | 2019 | 89 | |
| 17 | 2018 | 2 | |
| 18 | 2017 | 21 | |
| 19 | 2017 | 9 | |
| 20 | 2016 | 48 |
About Xing Feng
Xing Feng is a scholar working on Molecular Biology, Geriatrics and Gerontology and Immunology, having authored 29 papers that have together received 1.0k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (6 papers), Ubiquitin and proteasome pathways (4 papers), Histone Deacetylase Inhibitors Research (3 papers), Cancer-related gene regulation (3 papers), Autophagy in Disease and Therapy (3 papers), RNA modifications and cancer (3 papers), Biochemical and Molecular Research (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (337 citations), Molecular Biology (823 citations) and Physiology (30 citations). Xing Feng has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Zhiyong Zhang, Huiwen Song, Heng Zhang, He Huang, Junfei Jin, Yongxiang Zhao, Meihua Lin, Yun Luo, Xue Ding and Shu-Jing Wu. Their work appears in journals such as Nucleic Acids Research, The Journal of Experimental Medicine and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.